Resumes
Resumes
Terry Neher
View pageSkills:
Management
Leadership
Nonprofits
Leadership
Nonprofits
Terry Neher Phones & Addresses
-
Show Low, AZ
-
2400 Baseline Ave, Apache Junction, AZ 85219 (480) 983-2192
-
504 Rim Rd, Thayne, WY 83127 (307) 883-7228
-
San Tan Valley, AZ
-
1705 Stephanie Ln, Queen Creek, AZ 85142 (480) 983-2192
-
League City, TX
-
Superior, MT
-
Kent, WA
-
Mesa, AZ
-
1705 W Stephanie Ln, Queen Creek, AZ 85142
Skills
Management • Leadership • Nonprofits
Publications
Us Patents
Enkephalinase Inhibitor And Gaba Precursor Loading As Anti-Anxiety Compositions
View pageUS Patent:
20050163865, Jul 28, 2005
Filed:
Oct 29, 2004
Appl. No.:
10/977976
Inventors:
Albert Bieser - Houston TX, US
Terry Neher - Gold Canyon AZ, US
Terry Neher - Gold Canyon AZ, US
International Classification:
A61K033/32
A61K031/525
A61K031/4415
A61K031/375
A61K031/198
A61K031/185
A61K031/525
A61K031/4415
A61K031/375
A61K031/198
A61K031/185
US Classification:
424643000, 514251000, 514350000, 514474000, 514561000, 514553000, 514563000, 514567000
Abstract:
Benzodiazepine withdrawal induced anxiety is treated by administration of an enkephalinase inhibitor, and a gamma-aminobutyric acid (“GABA”) precursor, or an endorphin or enkephalin releaser. These components promote restoration of normal neurotransmitter function and are non-addictive. Use of the enkephalinase inhibitor D-phenylalanine, the GABA precursor glutamine, the serotonin precursor 5-HTP, glycine, and taurine, in combination with coenzymatic functionality of folic acid is preferred for activation of ligand-gated Cl channel in the central nervous system. Food supplement embodiments provide the human body nutritional supplements to intake certain neurotransmitter precursor substrates, thereby enabling patients of all ages to self-regulate their ability to quell perturbations to equilibrium and simultaneously to adverse effects upon normal physiological and psychological functioning attributable to induced anxiety and panic associated with benzodiazepine withdrawal.